Related Experiment Videos
Extraskeletal Myxoid Chondrosarcoma with Rhabdoid Features, with Special Reference to Its Aggressive Behavior
Yumi Oshiro1, Hideki Shiratsuchi, Sadafumi Tamiya
1Department of Anatomic Pathology, Graduate School of Medical Science, Kyushu University.
International Journal of Surgical Pathology
|August 9, 2001
Summary
Extraskeletal myxoid chondrosarcoma (EMC) with rhabdoid features indicates a poorer prognosis. These specific tumor cells signal more aggressive behavior in patients with this rare cancer.
Area of Science:
- Oncology
- Surgical Pathology
- Cancer Research
Background:
- Rhabdoid cells are observed in various malignant neoplasms.
- Extraskeletal myxoid chondrosarcoma (EMC) is a rare tumor.
- The significance of rhabdoid features in EMC was previously unclear.
Purpose of the Study:
- To investigate the clinicopathological significance of rhabdoid features in extraskeletal myxoid chondrosarcoma.
- To determine if rhabdoid morphology impacts patient prognosis in EMC.
Main Methods:
- Retrospective review of 36 extraskeletal myxoid chondrosarcoma cases.
- Histopathological analysis, including identification of rhabdoid cells.
- Immunohistochemical staining for cytokeratin (CAM 5.2) and vimentin.
- Survival analysis based on follow-up data.
Main Results:
- Three out of 36 EMC cases exhibited rhabdoid features characterized by eosinophilic cytoplasm.
- Cytokeratin positivity was observed in 15% of cases, including those with rhabdoid features.
- Cases with rhabdoid features showed a significantly poorer prognosis (p=0.0271).
- Five-year and 10-year survival rates were 73% and 63%, respectively, for EMC overall.
Conclusions:
- The presence of rhabdoid features in extraskeletal myxoid chondrosarcoma is associated with a significantly worse prognosis.
- Rhabdoid morphology may serve as a predictor of aggressive behavior in EMC, similar to its role in other mesenchymal neoplasms.